Estrella Immunopharma
ESLA
ESLA
11 hedge funds and large institutions have $560K invested in Estrella Immunopharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$30.5K |
| 2 |
HF
HRT Financial
New York
|
+$14K |
| 3 |
BlackRock
New York
|
+$6.48K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.51K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.71K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$35.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.01K |
| 3 |
JPMorgan Chase & Co
New York
|
-$21 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $242K | +$4.51K | +5,265 | +2% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $88.5K | +$2.71K | +3,164 | +3% |
|
|
3
UBS Group
Zurich,
Switzerland
| $69.9K | +$30.5K | +31,739 | +77% |
|
|
4
Citadel Advisors
Miami,
Florida
| $43K | -$35.5K | -41,443 | -45% |
|
|
ASM
5
ATW SPAC Management
New York
| $38.4K | – | – | – |
|
|
6
BlackRock
New York
| $30.2K | +$6.48K | +6,754 | +27% |
|
7
State Street
Boston,
Massachusetts
| $19.1K | – | – | – |
|
|
HF
8
HRT Financial
New York
| $14K | +$14K | +17,266 | New |
|
|
MCP
9
Maso Capital Partners
Hong Kong
| $9.6K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4.41K | -$1.01K | -1,053 | -19% |
|
11
Bank of America
Charlotte,
North Carolina
| $89 | +$5 | +5 | +6% |
|
|
12
JPMorgan Chase & Co
New York
| – | -$21 | -23 | Closed |
|